Eculizumab Side Effects
Not all side effects for eculizumab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to eculizumab: intravenous solution
In addition to its needed effects, some unwanted effects may be caused by eculizumab. In the event that any of these side effects do occur, they may require medical attention.
If any of the following side effects occur while taking eculizumab, check with your doctor or nurse immediately:More common
- Back pain
- black, tarry stools
- bladder pain
- bloody or cloudy urine
- blurred vision
- burning or stinging of the skin
- chest pain
- difficult, burning, or painful urination
- difficulty with moving
- joint pain
- lower back or side pain
- muscle aching or cramping
- muscle pains or stiffness
- pain or tenderness around the eyes and cheekbones
- painful cold sores or blisters on the lips, nose, eyes, or genitals
- pale skin
- pounding in the ears
- shortness of breath or troubled breathing
- slow or fast heartbeat
- sore throat
- sores, ulcers, or white spots on lips or in the mouth
- stuffy or runny nose
- swollen glands
- swollen joints
- tightness of the chest or wheezing
- troubled breathing with exertion
- unusual bleeding or bruising
- unusual tiredness or weakness
- general feeling of discomfort or illness
- loss of appetite
- trouble sleeping
Some of the side effects that can occur with eculizumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:More common
- Difficulty having a bowel movement (stool)
- pain in the arms or legs
For Healthcare Professionals
Applies to eculizumab: intravenous solution
Immunologic side effects have included herpes simplex infections (up to 7%), influenza-like illness (up to 5%), and immunogenicity (antibodies to eculizumab detected in up to 3% of patients). Postmarketing cases of serious or fatal meningococcal infections have also been reported.[Ref]
Respiratory side effects have included upper respiratory tract infection (up to 35%), nasopharyngitis (up to 23%), cough ( up to 14%), pharyngolaryngeal pain (up to 14%), sinusitis (up to 7%), and low titers of antibodies to eculizumab (up to 3%).[Ref]
Musculoskeletal side effects have included back pain (up to 19%), pain in extremity (up to 11%), arthralgia (up to 7%), and myalgia (up to 7%).[Ref]
Gastrointestinal side effects have included diarrhea (up to 32%), vomiting (up to 22%), nausea (up to 19%), abdominal pain (up to 11%), and constipation (up to 7%).[Ref]
Hematologic side effects have included anemia (up to 24%), and leukopenia (up to 16%).[Ref]
Cardiovascular side effects have included hypertension (up to 35%).
Nervous system side effects have included headache (up to 44%), vertigo (up to 11%), and dizziness (up to 5%).[Ref]
General side effects have included fatigue (up to 12%), peripheral edema (up to 11%), and pyrexia (up to 11%).
Psychiatric side effects have included insomnia (up to 14%).
Genitourinary side effects have included urinary tract infection (up to 16%).
1. "Product Information. Soliris (eculizumab)." Alexion Pharmaceuticals Inc, Cheshire, CT.
2. Hillmen P, Young NS, Schubert J, et al. "The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria." N Engl J Med 355 (2006): 1233-43
More about eculizumab
- Other brands: Soliris
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.